Search results
Showing 676 to 690 of 9039 results
This quality standard covers the management of colorectal (bowel) cancer in adults. It includes managing local disease and secondary tumours (metastatic disease). It describes high-quality care in priority areas for improvement.
View quality statements for QS20Show all sections
Sections for QS20
- Quality statements
- Quality statement 1: Testing for Lynch syndrome
- Quality statement 2: Discussion about treatment options for early rectal cancer
- Quality statement 3: Testing to guide systemic anti-cancer treatment
- Quality statement 4: Follow-up for detecting local recurrence and distant metastases
- Update information
- About this quality standard
All NICE products on injuries, accidents and wounds. Includes any guidance, advice and quality standards.
All NICE products on delirium. Includes any guidance and quality standards.
All NICE products on renal stones. Includes any guidance, advice and quality standards.
All NICE products on chronic kidney disease. Includes any guidance, advice and quality standards.
All NICE products on acute kidney injury. Includes any guidance, advice and quality standards.
All NICE products on psoriasis. Includes any guidance and quality standards.
All NICE products on physical activity. Includes any guidance and quality standards.
All NICE products on cholelithiasis and cholecystitis. Includes any guidance and quality standards.
All NICE products on varicose veins. Includes any guidance and quality standards.
All NICE products on structural heart defects. Includes any guidance and advice.
All NICE products on allergies and anaphylaxis. Includes any guidance, advice and quality standards.
All NICE products on bipolar disorder. Includes any guidance and quality standards.
This webpage covers all NICE's guidelines on women's and reproductive health. The table presents the guidelines alphabetically. Updates planned or in...
This quality standard covers diagnosing and managing bladder cancer in adults (aged 18 and over) referred from primary care. It describes high-quality care in priority areas for improvement.
View quality statements for QS106Show all sections
Sections for QS106
- Quality statements
- Quality statement 1: Obtaining detrusor muscle during transurethral resection of bladder tumour
- Quality statement 2: Chemotherapy during transurethral resection of bladder tumour
- Quality statement 3: Access to a clinical nurse specialist
- Quality statement 4: Risk classification
- Quality statement 5: Discussing treatment options for high-risk non-muscle-invasive bladder cancer
- Quality statement 6: Discussing treatment options for muscle-invasive urothelial bladder cancer
- Quality statement 7: Discharge to primary care